| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 T Hueso, C Pouderoux, H Péré, AL Beaumont, LA Raillon, F Ader, ... Blood, The Journal of the American Society of Hematology 136 (20), 2290-2295, 2020 | 286 | 2020 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 275 | 2021 |
| Shiga toxin-associated hemolytic uremic syndrome: A narrative review A Joseph, A Cointe, P Mariani Kurkdjian, C Rafat, A Hertig Toxins 12 (2), 67, 2020 | 186 | 2020 |
| Orthostatic hypotension: a review A Joseph, R Wanono, M Flamant, E Vidal-Petiot Nephrologie & therapeutique 13, S55-S67, 2017 | 122 | 2017 |
| Metabolic vulnerability of cisplatin‐resistant cancers F Obrist, J Michels, S Durand, A Chery, J Pol, S Levesque, A Joseph, ... The EMBO journal 37 (14), e98597, 2018 | 93 | 2018 |
| Acute kidney injury in patients with SARS-CoV-2 infection A Joseph, L Zafrani, A Mabrouki, E Azoulay, M Darmon Annals of Intensive Care 10, 1-8, 2020 | 89 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 76 | 2022 |
| Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 N de Prost, E Audureau, N Heming, E Gault, T Pham, A Chaghouri, ... Nature Communications 13 (1), 6025, 2022 | 42 | 2022 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
| One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: a retrospective study E Borcoman, A Dupont, E Mariotte, L Doucet, A Joseph, A Chermak, ... Journal of Critical Care 57, 36-41, 2020 | 31 | 2020 |
| Shiga toxin-associated hemolytic uremic syndrome: specificities of adult patients and implications for critical care management B Travert, C Rafat, P Mariani, A Cointe, A Dossier, P Coppo, A Joseph Toxins 13 (5), 306, 2021 | 25 | 2021 |
| Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit A Joseph, A Simonaggio, A Stoclin, A Vieillard-Baron, G Geri, S Oudard, ... Annals of Intensive Care 10, 1-11, 2020 | 25 | 2020 |
| Multifaceted modes of action of the anticancer probiotic Enterococcus hirae AG Goubet, R Wheeler, A Fluckiger, B Qu, F Lemaître, K Iribarren, ... Cell Death & Differentiation 28 (7), 2276-2295, 2021 | 22 | 2021 |
| Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI) A Joseph, S Moriceau, V Sica, G Anagnostopoulos, J Pol, I Martins, ... Cell Death & Disease 11 (7), 502, 2020 | 21 | 2020 |
| Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French … A Lafarge, A Joseph, C Pagnoux, X Puéchal, P Cohen, M Samson, ... Rheumatology 59 (9), 2250-2257, 2020 | 19 | 2020 |
| Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index A Joseph, H Chen, G Anagnostopoulos, L Montégut, A Lafarge, O Motiño, ... Cell Death & Disease 12 (6), 599, 2021 | 17 | 2021 |
| Metabolic enzymes expressed by cancer cells impact the immune infiltrate G Stoll, M Kremer, N Bloy, A Joseph, M Castedo, G Meurice, C Klein, ... Oncoimmunology 8 (6), e1571389, 2019 | 14 | 2019 |
| Early differentiation of Shiga toxin–associated hemolytic uremic syndrome in critically ill adults with thrombotic microangiopathy syndromes A Joseph, C Rafat, L Zafrani, P Mariani-Kurkdjian, A Veyradier, A Hertig, ... Critical Care Medicine 46 (9), e904-e911, 2018 | 14 | 2018 |
| Metabolic features of cancer cells impact immunosurveillance A Joseph, P Juncheng, M Mondini, N Labaied, M Loi, J Adam, A Lafarge, ... Journal for Immunotherapy of Cancer 9 (6), 2021 | 12 | 2021 |
